Drugs / ONO-2333Ms
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00514865 | Jun 2007 → Apr 2008 | major depressive disorder | Ono Pharma USA Inc | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONO-2333Ms | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00514865 ↗ |
| Action | Inhibit | “Corticotropin releasing factor receptor 1 antagonist” CHEMBL1819077 ↗ |
| Modality | Small molecule | — CHEMBL1819077 ↗ |
| Target | CRHR1 | “Corticotropin releasing factor receptor 1 antagonist” CHEMBL1819077 ↗ |